跳至主要内容
临床试验/NCT01956500
NCT01956500已完成不适用

Influence of Instaflex Joint Support Supplement on Joint Pain, Stiffness, Function, and Inflammation: a Randomized, Placebo-controlled Community Trial

Appalachian State University1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2013年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
1
主要终点
Joint pain and function

研究概览

简要总结

The primary purpose of this study is to assess the effect of 8-weeks ingestion of the Instaflex Joint Support supplement (Direct Digital, Charlotte, NC) compared to placebo on joint pain, stiffness, and function (questionnaires and 6-min walk test) and blood inflammation biomarkers in adults with self-reported joint pain.

详细描述

Allocation: Randomized. Subjects will be randomized to one of two groups: placebo or Instaflex Joint Support. Supplements will be administered in double-blinded fashion.

Intervention Model: Instaflex Joint Support supplement for 8 weeks versus placebo.

Sample Size: N=100, with N=50 per group.

Statistical Procedures: 2 x 2 repeated measures analysis of variance (ANOVA).

Study Duration (per subject): 8 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Male or female
  • •ages 50-75 years
  • •history (>3 months) joint pain, knees, hip, ankles, shoulders, or hands
  • •willingness to avoid NSAIDs use during the 8-week study
  • •willingness to avoid other anti-inflammatory medications
  • •agree to stay weight stable during the 8-week study
  • •willing to follow all study procedures, including randomization to one of two groups
  • •able to walk for at least 6 min at a moderate-to-brisk pace

排除标准

  • •history of regular NSAID use during the previous two weeks
  • •use of other medications (e.g., analgesic gels, arthritis medications, other anti-inflammatory drugs) or supplements (in particular, glucosamine and chondroitin) for joint pain for the previous two weeks
  • •serious medical problems (current cancer case, severe rheumatoid arthritis, recent heart attack, recent stroke, congestive heart failure, ulcers, kidney disease, or other disease that will interfere with study participation).
  • •psychiatric disorder or other condition that might interfere with self-assessment ability.
  • •history of allergic reactions to shellfish products.
  • •history of allergic reactions to products containing aspirin.

研究组 & 干预措施

Instaflex

Experimental

Instaflex Joint Support supplement (3 capsules per day for 8 weeks)

干预措施: Instaflex (Dietary Supplement)

Placebo

Placebo Comparator

Placebo (3 capsules per day for 8 weeks)

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Joint pain and function

时间窗: Change in joint pain and function at 8 weeks

Assessed through questionnaires

次要结局

  • Systemic inflammation(Change in systemic inflammation at 8 weeks)
  • Safety(Change in safety outcomes at 8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Instaflex and Joint Pain in Community Adults | 临床试验